FREMONT, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM" or the "Company") (NASDAQ:ACMR), a provider of single-wafer wet cleaning equipment used by manufacturers of advanced semiconductors, today reported financial results for its fourth quarter and fiscal year ended December 31, 2018.
ACM's President and Chief Executive Officer Dr. David Wang commented, "Our strong financial performance in 2018 was a result of robust customer demand and crisp execution. We delivered 104% revenue growth, expanded operating margins, and generated $6.9 million in cash flow from operations. In addition to strong financial results, we made significant operating progress in 2018. We ramped production at our second factory, delivered a significant number of first tools, and introduced our newest major platform, the Ultra-C Tahoe."
Dr. Wang continued, "As we head into 2019, we continue to see solid business momentum. We are committed to achieving our vision of becoming a major player in the semiconductor equipment market, and we look forward to delivering another strong year in 2019."
Operating Highlights
Financial Summary | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Three Months Ended December 31, | ||||||||||||||||
GAAP | Non-GAAP(1) | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
(dollars in thousands) | ||||||||||||||||
Revenue | $ | 20,848 | $ | 17,192 | $ | 20,848 | $ | 17,192 | ||||||||
Gross margin(2) | 49.5 | % | 53.4 | % | 49.6 | % | 53.4 | % | ||||||||
Income from operations(2) | $ | 2,640 | $ | 3,765 | $ | 3,232 | $ | 3,696 | ||||||||
Net income attributable to ACM Research, Inc.(2) | $ | 2,286 | $ | 3,384 | $ | 2,878 | $ | 3,315 | ||||||||
Basic EPS(2) | $ | 0.14 | $ | 0.28 | $ | 0.18 | $ | 0.28 | ||||||||
Diluted EPS(2) | $ | 0.13 | $ | 0.25 | $ | 0.16 | $ | 0.24 |
Twelve Months Ended December 31, | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GAAP | Non-GAAP(1) | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
(dollars in thousands) | ||||||||||||||||
Revenue | $ | 74,643 | $ | 36,506 | $ | 74,643 | $ | 36,506 | ||||||||
Gross margin(2) | 46.2 | % | 47.2 | % | 46.2 | % | 47.2 | % | ||||||||
Income from operations(2) | $ | 6,471 | $ | 700 | $ | 9,834 | $ | 2,323 | ||||||||
Net income (loss) attributable to ACM Research, Inc.(2) | $ | 6,574 | $ | (318 | ) | $ | 9,937 | $ | 1,305 | |||||||
Basic EPS(2) | $ | 0.42 | $ | (0.05 | ) | $ | 0.63 | $ | 0.19 | |||||||
Diluted EPS(2) | $ | 0.37 | $ | (0.05 | ) | $ | 0.55 | $ | 0.15 |
________________________
(1) Reconciliations to U.S. generally accepted accounting principles ("GAAP") financial measures from non-GAAP financial measures are presented below under "Reconciliation of GAAP to Non-GAAP Financial Measures."
(2) Non-GAAP financial measures exclude stock-based compensation.
Outlook
For fiscal year 2019, the Company expects revenue to be approximately $100 million.
Conference Call Details
A conference call to discuss results will be held on Thursday, March 7, 2019 at 8:00 a.m. Eastern Time (9:00 p.m. China Time). Dial-in details for the call are as follows. Please reference conference ID 8884467.
Phone Number | Toll-Free Number | |
---|---|---|
United States | +1 (845) 675-0437 | +1 (866) 519-4004 |
Hong Kong | +852 3018 6771 | +852 8009 06601 |
Mainland China | +86 (800) 819 0121 | |
+86 (400) 620 8038 | ||
Other International | +65 6713 5090 |
A recording of the webcast will be available on the investor page of the ACM website at www.acmrcsh.com for one week following the call.
Use of Non-GAAP Financial Measures
ACM presents non-GAAP gross margin, operating income , net income (loss) and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM Research's operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under "Reconciliation of Non-GAAP to GAAP Financial Measures."
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM Research's consolidated financial statements prepared in accordance with GAAP.
Forward-Looking Statements
Information presented in the third paragraph of this press release and under the heading "Outlook" above contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from ACM Research's expectations based on a number of risks and uncertainties, including but not limited to the following: anticipated customer orders or identified market opportunities may not grow or develop as anticipated; customer orders already received may be postponed or canceled; suppliers may not be able to meet ACM Research's demands on a timely basis; volatile global economic, market, industry and other conditions could result in sharply lower demand for products containing semiconductors and for the company's products and in disruption of capital and credit markets; ACM Research's failure to successfully manage its operations; and trade regulations, currency fluctuations, political instability and war may materially adversely affect ACM due to its substantial non-U.S. customer and supplier base and its substantial non-U.S. manufacturing operations. ACM cannot guarantee any future results, levels of activity, performance or achievements. ACM expressly disclaims any obligation to update forward-looking statements after the date of this press release.
About ACM Research, Inc.
ACM develops, manufactures and sells single-wafer wet cleaning equipment, which semiconductor manufacturers can use in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield, in fabricating advanced integrated circuits.
© ACM Research, Inc. The ACM logo is a trademark of ACM Research, Inc. All rights reserved. Any other trademarks are the property of their respective owners.
For investor and media inquiries, please contact: | ||
---|---|---|
In the United States: | The Blueshirt Group | |
Ralph Fong | ||
+1 (415) 489-2195 | ||
ralph@blueshirtgroup.com | ||
In China: | The Blueshirt Group Asia | |
Gary Dvorchak, CFA | ||
+86 (138) 1079-1480 | ||
gary@blueshirtgroup.com |
ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets
December 31, 2018 | December 31, 2017 | ||||||
---|---|---|---|---|---|---|---|
(unaudited) | |||||||
(in thousands, except share and per sharedata) | |||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 27,124 | $ | 17,681 | |||
Accounts receivable, less allowance for doubtful accounts of $0 as ofDecember 31, 2018 and $0 as of December 31, 2017 | 24,608 | 26,762 | |||||
Other receivables | 3,547 | 2,491 | |||||
Inventories | 38,764 | 15,388 | |||||
Prepaid expenses | 1,985 | 546 | |||||
Other current assets | - | 46 | |||||
Total current assets | 96,028 | 62,914 | |||||
Property, plant and equipment, net | 3,708 | 2,340 | |||||
Intangible assets, net | 274 | 106 | |||||
Deferred tax assets | 1,637 | 1,294 | |||||
Investment in affiliates, equity method | 1,360 | 1,237 | |||||
Other long-term assets | 40 | - | |||||
Total assets | 103,047 | 67,891 | |||||
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Short-term borrowings | 9,447 | 5,095 | |||||
Warrant liability | - | 3,079 | |||||
Accounts payable | 16,673 | 7,419 | |||||
Advances from customers | 8,417 | 143 | |||||
Income taxes payable | 1,193 | 44 | |||||
Other payables and accrued expenses | 10,410 | 6,037 | |||||
Total current liabilities | 46,140 | 21,817 | |||||
Other long-term liabilities | 4,583 | 6,217 | |||||
Total liabilities | 50,723 | 28,034 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Common stock - Class A, par value $0.0001: 100,000,000 shares authorized as of December 31, 2018and 2017; 14,110,315 shares issued and outstanding as of December 31, 2018 and 12,935,546 sharesissued and outstanding as of December 31, 2017 | 1 | 1 | |||||
Common stock-Class B, par value $0.0001: 7,303,533 shares authorized as of December 31, 2018 and2017; 1,898,423 shares issued and outstanding as of December 31, 2018 and 2,409,738 shares issuedand outstanding as of December 31, 2017 | - | - | |||||
Additional paid in capital | 56,567 | 49,695 | |||||
Accumulated deficit | (3,387 | ) | (9,961 | ) | |||
Accumulated other comprehensive income (loss) | (857 | ) | 122 | ||||
Total stockholders' equity | 52,324 | 39,857 | |||||
Total liabilities and stockholders' equity | $ | 103,047 | $ | 67,891 |
ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Loss
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018 | 2017 | 2018 | 2017 | ||||||||||||
( In thousands, except share and per share data) | ( In thousands, except share and per share data) | ||||||||||||||
Revenue | $ | 20,848 | $ | 17,192 | $ | 74,643 | $ | 36,506 | |||||||
Cost of revenue | 10,532 | 8,019 | 40,194 | 19,281 | |||||||||||
Gross profit | 10,316 | 9,173 | 34,449 | 17,225 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 1,845 | 1,881 | 9,611 | 5,500 | |||||||||||
Research and development | 4,156 | 2,062 | 10,380 | 5,138 | |||||||||||
General and administrative | 1,675 | 1,465 | 7,987 | 5,887 | |||||||||||
Total operating expenses, net | 7,676 | 5,408 | 27,978 | 16,525 | |||||||||||
Income (loss) from operations | 2,640 | 3,765 | 6,471 | 700 | |||||||||||
Interest income | 9 | 2 | 29 | 9 | |||||||||||
Interest expense | (134 | ) | (80 | ) | (498 | ) | (277 | ) | |||||||
Other expense, net | 42 | (263 | ) | 1,255 | (794 | ) | |||||||||
Equity income in net income of affiliates | (112 | ) | 17 | 123 | 37 | ||||||||||
Income (loss) before income taxes | 2,445 | 3,441 | 7,380 | (325 | ) | ||||||||||
Income tax benefit (expense) | (159 | ) | (76 | ) | (806 | ) | (547 | ) | |||||||
Net income (loss) | 2,286 | 3,365 | 6,574 | (872 | ) | ||||||||||
Less: Net income (loss) attributable to non-controlling interests | - | (19 | ) | - | (554 | ) | |||||||||
Net income (loss) attributable to ACM Research, Inc. | $ | 2,286 | $ | 3,384 | $ | 6,574 | $ | (318 | ) | ||||||
Comprehensive income (loss) | |||||||||||||||
Net income (loss) | 2,286 | 3,365 | 6,574 | (872 | ) | ||||||||||
Foreign currency translation adjustment | 98 | (20 | ) | (979 | ) | 472 | |||||||||
Comprehensive income (loss) | 2,384 | 3,345 | 5,595 | (400 | ) | ||||||||||
Less: Comprehensive income (loss) attributable to non-controlling interests | - | (22 | ) | - | (369 | ) | |||||||||
Total comprehensive income (loss) attributable to ACM Research, Inc. | $ | 2,384 | $ | 3,367 | $ | 5,595 | $ | (31 | ) | ||||||
Net income (loss) attributable to ACM Research, Inc. per common share : | |||||||||||||||
Basic | $ | 0.14 | $ | 0.28 | $ | 0.42 | $ | (0.05 | ) | ||||||
Diluted | $ | 0.13 | $ | 0.25 | $ | 0.37 | $ | (0.05 | ) | ||||||
Weighted average common shares outstanding used in computing per share amounts: | |||||||||||||||
Basic | 16,004,781 | 12,013,651 | 15,788,460 | 6,865,390 | |||||||||||
Diluted | 18,115,071 | 13,587,443 | 17,912,105 | 6,865,390 |
ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
As described under "Use of Non-GAAP Financial Measures" above, ACM presents non-GAAP gross margin, operating income and net income (loss) as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation ("SBC") from the equivalent GAAP financial line items. The following tables reconcile gross margin, operating income and net income (loss) to the related non-GAAP financial measures:
Three Months Ended December 31, | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018 | 2017 | |||||||||||||||||
Actual | SBC | Adjusted | Actual | SBC | Adjusted | |||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||
(in thousands) | ||||||||||||||||||
Revenue | $ | 20,848 | $ | - | $ | 20,848 | $ | 17,192 | $ | - | $ | 17,192 | ||||||
Cost of revenue | (10,532 | ) | (27 | ) | (10,505 | ) | (8,019 | ) | (6 | ) | (8,013 | ) | ||||||
Gross profit | 10,316 | (27 | ) | 10,343 | 9,173 | (6 | ) | 9,179 | ||||||||||
Operating expenses: | ||||||||||||||||||
Sales and marketing | (1,845 | ) | (5 | ) | (1,840 | ) | (1,881 | ) | (18 | ) | (1,863 | ) | ||||||
Research and development | (4,156 | ) | (124 | ) | (4,032 | ) | (2,062 | ) | (12 | ) | (2,050 | ) | ||||||
General and administrative | (1,675 | ) | (436 | ) | (1,239 | ) | (1,465 | ) | 105 | (1,570 | ) | |||||||
Income (Loss) from operations | $ | 2,640 | $ | (592 | ) | $ | 3,232 | $ | 3,765 | $ | 69 | $ | 3,696 | |||||
Net income (loss) attributable to ACM Research, Inc. | $ | 2,286 | $ | (592 | ) | $ | 2,878 | $ | 3,384 | $ | 69 | $ | 3,315 | |||||
Net income (loss) attributable to ACM Research, Inc. per common share : | ||||||||||||||||||
Basic | $ | 0.14 | $ | (0.04 | ) | $ | 0.18 | $ | 0.28 | $ | 0.01 | $ | 0.28 | |||||
Diluted | $ | 0.13 | $ | (0.03 | ) | $ | 0.16 | $ | 0.25 | $ | 0.01 | $ | 0.24 | |||||
Twelve Months Ended December 31, | ||||||||||||||||||
2018 | 2017 | |||||||||||||||||
Actual | SBC | Adjusted | Actual | SBC | Adjusted | |||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||
(in thousands) | ||||||||||||||||||
Revenue | $ | 74,643 | $ | - | $ | 74,643 | $ | 36,506 | $ | - | $ | 36,506 | ||||||
Cost of revenue | (40,194 | ) | (71 | ) | (40,123 | ) | (19,281 | ) | (21 | ) | (19,260 | ) | ||||||
Gross profit | 34,449 | (71 | ) | 34,520 | 17,225 | (21 | ) | 17,246 | ||||||||||
Operating expenses: | ||||||||||||||||||
Sales and marketing | (9,611 | ) | (120 | ) | (9,491 | ) | (5,500 | ) | (53 | ) | (5,447 | ) | ||||||
Research and development | (10,380 | ) | (255 | ) | (10,125 | ) | (5,138 | ) | (50 | ) | (5,088 | ) | ||||||
General and administrative | (7,987 | ) | (2,917 | ) | (5,070 | ) | (5,887 | ) | (1,499 | ) | (4,388 | ) | ||||||
Income (Loss) from operations | $ | 6,471 | $ | (3,363 | ) | $ | 9,834 | $ | 700 | $ | (1,623 | ) | $ | 2,323 | ||||
Net income (loss) attributable to ACM Research, Inc. | $ | 6,574 | $ | (3,363 | ) | $ | 9,937 | $ | (318 | ) | $ | (1,623 | ) | $ | 1,305 | |||
Net income (loss) attributable to ACM Research, Inc. per common share : | ||||||||||||||||||
Basic | $ | 0.42 | $ | (0.21 | ) | $ | 0.63 | $ | (0.05 | ) | $ | (0.24 | ) | $ | 0.19 | |||
Diluted | $ | 0.37 | $ | (0.19 | ) | $ | 0.55 | $ | (0.05 | ) | $ | (0.24 | ) | $ | 0.15 |
Source: ACM Research (Shanghai), Inc.